We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+8.57%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.59%
AUM
$3.6B
AUM Growth
-$633M
Cap. Flow
-$550M
Cap. Flow %
-15.3%
Top 10 Hldgs %
58.29%
Holding
479
New
155
Increased
61
Reduced
86
Closed
113

Top Buys

1
SKX
Skechers
SKX
+$207M
2
BPMC
Blueprint Medicines
BPMC
+$176M
3
WBA
Walgreens Boots Alliance
WBA
+$167M
4
DNB
Dun & Bradstreet
DNB
+$122M
5
INFA
Informatica
INFA
+$93.8M

Top Sells

1
DFS
Discover Financial Services
DFS
+$408M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$408M
3
HES
Hess
HES
+$251M
4
BECN
Beacon Roofing Supply, Inc.
BECN
+$195M
5
BERY
Berry Global Group, Inc.
BERY
+$137M

Sector Composition

1 Healthcare 20.27%
2 Technology 14.64%
3 Consumer Staples 11.26%
4 Energy 10.11%
5 Consumer Discretionary 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIGL icon
151
Rigel Pharmaceuticals
RIGL
$771M
$1.96M 0.05%
104,890
-5,494
-5% -$104K
OCUL icon
152
Ocular Therapeutix
OCUL
$2.01B
$1.95M 0.05%
210,205
-48,158
-19% -$377K
ADT icon
153
ADT
ADT
$5.18B
$1.94M 0.05%
229,607
– –
MGNI icon
154
CALL
Magnite
MGNI
$2.85B
$1.93M 0.05%
432,000
+325,000
+304% +$4.79M
MRVL icon
155
Marvell Technology
MRVL
$169B
$1.91M 0.05%
+24,688
New +$1.54M
AGIO icon
156
Agios Pharmaceuticals
AGIO
$2.3B
$1.89M 0.05%
56,810
-1,912
-3% -$58K
LOKV
157
DELISTED
Live Oak Acquisition Corp V
LOKV
$1.87M 0.05%
+174,923
New +$1.8M
CCJ icon
158
Cameco
CCJ
$38B
$1.86M 0.05%
+25,000
New +$1.33M
VRDN icon
159
Viridian Therapeutics
VRDN
$1.99B
$1.84M 0.05%
131,294
+24,206
+23% +$329K
IMCR icon
160
Immunocore
IMCR
$1.75B
$1.67M 0.05%
53,343
+8,147
+18% +$253K
CAT icon
161
Caterpillar
CAT
$404B
$1.63M 0.05%
+4,200
New +$1.4M
IQV icon
162
IQVIA
IQV
$35.1B
$1.62M 0.05%
10,275
+5,275
+106% +$794K
AACB
163
Artius II Acquisition Inc
AACB
$293M
$1.62M 0.05%
+160,000
New +$1.6M
POLE
164
Andretti Acquisition Corp II
POLE
$318M
$1.56M 0.04%
150,000
– –
TMO icon
165
Thermo Fisher Scientific
TMO
$202B
$1.53M 0.04%
+3,770
New +$1.58M
SOUL
166
Soulpower Acquisition Corp
SOUL
$353M
$1.51M 0.04%
+150,000
New +$1.5M
VIST icon
167
Vista Energy
VIST
$6.95B
$1.5M 0.04%
+31,391
New +$1.49M
GPRK icon
168
GeoPark
GPRK
$618M
$1.49M 0.04%
+228,367
New +$1.56M
WMT icon
169
Walmart Inc
WMT
$915B
$1.47M 0.04%
15,000
-15,000
-50% -$1.43M
PRCT icon
170
Procept Biorobotics
PRCT
$1.09B
$1.45M 0.04%
25,226
-2,774
-10% -$157K
KIDS icon
171
OrthoPediatrics
KIDS
$523M
$1.41M 0.04%
65,866
-8,996
-12% -$194K
HLT icon
172
Hilton Worldwide
HLT
$73.6B
$1.33M 0.04%
+5,000
New +$1.19M
ATEC icon
173
Alphatec Holdings
ATEC
$1.43B
$1.32M 0.04%
119,094
-75,143
-39% -$863K
AUTL
174
Autolus Therapeutics
AUTL
$389M
$1.29M 0.04%
+565,000
New +$934K
SN icon
175
SharkNinja
SN
$21.8B
$1.29M 0.04%
13,000
-22,000
-63% -$1.9M
5 6
7
8 9

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RCM
RNC Capital Management Los Angeles, California $2.2B AUM 22.93% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

UBS O'Connor's Q2 2025 Portfolio in Review

As of Q2 2025, UBS O'Connor held 479 positions worth $3.6B, down 15% from $4.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

UBS O'Connor withdrew a net $550M in Q2 2025, closing 113 positions and reducing 86 holdings. Its most notable exit was Discover Financial Services, an estimated $408M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in Skechers worth $227M.

  • UBS O'Connor's largest Q2 2025 buy was Skechers: 3,598,177 shares worth $227M.
  • UBS O'Connor added most to Blueprint Medicines in Q2 2025, an estimated $176M increase.
  • UBS O'Connor's biggest Q2 2025 reduction was Hess, cutting an estimated $251M.
  • UBS O'Connor fully exited Discover Financial Services in Q2 2025, selling an estimated $408M.
  • UBS O'Connor's ten largest holdings make up 58% of its $3.6B portfolio in Q2 2025.
  • UBS O'Connor opened 155 new positions and closed 113 in Q2 2025.
  • UBS O'Connor's portfolio value fell 15% quarter-over-quarter to $3.6B.

Based on UBS O'Connor's 13F filing for Q2 2025, filed 14 Aug 2025.